| Slideshow corporate presentation 2Q 2010 |
| Slideshow financials for 2009 |
| Slideshow call conference, Sept 2009: Interim Phase I/II clinical data in fNLH |
| Slideshow: Analysts update H109 |
| Slideshow call conference, June 2009: Positive Phase IIa clinical results for IPH 1101 in HCV |
| Slideshow financials for 2008 |
| Slideshow Eurobio, October 2008: Acquisition of full rights to IPH 2101 |
